PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,818 | -91.3% | 176 | -88.9% | 0.00% | – |
| Q2 2023 | $20,792 | -19.7% | 1,586 | -31.5% | 0.00% | – |
| Q1 2023 | $25,893 | +337.5% | 2,316 | +229.9% | 0.00% | – |
| Q4 2022 | $5,918 | -15.5% | 702 | +75.5% | 0.00% | – |
| Q3 2022 | $7,000 | 0.0% | 400 | -14.2% | 0.00% | – |
| Q2 2022 | $7,000 | -30.0% | 466 | +23.6% | 0.00% | – |
| Q1 2022 | $10,000 | -80.4% | 377 | -76.3% | 0.00% | – |
| Q4 2021 | $51,000 | +37.8% | 1,590 | +54.4% | 0.00% | – |
| Q3 2021 | $37,000 | +68.2% | 1,030 | +107.7% | 0.00% | – |
| Q2 2021 | $22,000 | – | 496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |